Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 1467 entries
View as:

A Study to Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With Placebo

Phase: N/A Priority: Normal
NCT ID: NCT06015308 Org: User:
Start: 10/06/23 End: 02/27/26 Due: 02/27/27

Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00679588 Org: User:
Start: 04/30/08 End: 08/31/10 Due: 08/31/11

Acceptability Dermacyd Delicata - New Fragrance - Lactoserum - Hygiene

Phase: N/A Priority: Normal
NCT ID: NCT00370162 Org: User:
Start: 06/30/06 End: - Due: -

Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00290966 Org: User:
Start: 10/31/98 End: 05/31/03 Due: 05/31/04

Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02528214 Org: User:
Start: 10/15/15 End: 11/13/17 Due: 11/13/18

Evaluation of the Safety and Efficacy of Insulin Glargine 300 U/ml (Gla-300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus Uncontrolled on Oral Antihyperglycemic Drugs

Phase: N/A Priority: Normal
NCT ID: NCT04980027 Org: User:
Start: 06/07/21 End: 12/23/22 Due: 12/23/23

Study of a Quadrivalent Meningococcal Conjugate Vaccine as a Single Dose Compared With a Single Dose of a Meningococcal Reference Vaccine in Children, Adolescents, and Adults 2 to 55 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT04368429 Org: User:
Start: 05/22/20 End: 11/07/20 Due: 11/07/21

Study to Evaluate the Response Rate to Therapy With Docetaxel and Cisplatin in Unresectable Locally Advanced Squamous Cell Carcinoma of Head and Neck

Phase: N/A Priority: Normal
NCT ID: NCT02061631 Org: User:
Start: 05/31/14 End: 10/31/15 Due: 10/31/16

Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT03449758 Org: User:
Start: 03/05/18 End: 07/31/19 Due: 07/31/20

Long-term Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) With Venglustat

Phase: N/A Priority: Normal
NCT ID: NCT04705051 Org: User:
Start: 02/09/21 End: 07/13/21 Due: 07/13/22

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)

Phase: N/A Priority: Normal
NCT ID: NCT06181435 Org: User:
Start: 12/21/23 End: 04/06/26 Due: 04/06/27

SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"

Phase: N/A Priority: Normal
NCT ID: NCT04033367 Org: User:
Start: 08/22/19 End: 10/06/21 Due: 10/06/22

Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01623115 Org: User:
Start: 07/31/12 End: 12/31/14 Due: 12/31/15

Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma

Phase: N/A Priority: Normal
NCT ID: NCT05421598 Org: User:
Start: 06/30/22 End: 03/20/25 Due: 03/20/26

OPAL - Insulin Glulisine, Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00272012 Org: User:
Start: 07/31/04 End: - Due: -

Docetaxel in Non Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00432315 Org: User:
Start: 05/31/01 End: 10/31/09 Due: 10/31/10

Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Perennial Allergic Rhinitis (PAR)

Phase: N/A Priority: Normal
NCT ID: NCT01244217 Org: User:
Start: 10/31/10 End: 08/31/11 Due: 08/31/12

Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen

Phase: N/A Priority: Normal
NCT ID: NCT00561470 Org: User:
Start: 11/30/07 End: 06/30/12 Due: 06/30/13

Study of SAR447537 (INBRX-101) Compared to Plasma-derived A1PI Therapy in Adults With AATD Emphysema

Phase: N/A Priority: Normal
NCT ID: NCT05856331 Org: User:
Start: 10/12/23 End: 10/30/25 Due: 10/30/26

An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)

Phase: N/A Priority: Normal
NCT ID: NCT02776735 Org: User:
Start: 09/06/16 End: 12/27/23 Due: 12/27/24

Observational Registry of Treatment Patterns in Castrate-resistant Prostate Cancer (CRPC) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01076751 Org: User:
Start: 02/28/10 End: 10/31/10 Due: 10/31/11

Effect of Alirocumab on Lipid Metabolism in Adults With Elevated LDL-Cholesterol

Phase: N/A Priority: Normal
NCT ID: NCT01959971 Org: User:
Start: 12/31/13 End: 05/31/15 Due: 05/31/16

An Observational, Retrospective Multicentre Medical Record Review to Describe the Post-authorisation Early Clinical Experience of Dupilumab in the Treatment of Adult Severe Asthma

Phase: N/A Priority: Normal
NCT ID: NCT06064526 Org: User:
Start: 04/19/23 End: 10/15/24 Due: 10/15/25

A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomy

Phase: N/A Priority: Normal
NCT ID: NCT00069888 Org: User:
Start: 11/30/01 End: 01/31/07 Due: 01/31/08

Irbesartan in Chinese Hypertensive Diabetics With Microalbuminuria

Phase: N/A Priority: Normal
NCT ID: NCT00334581 Org: User:
Start: 05/31/06 End: 06/30/08 Due: 06/30/09